Alopecia areata
Not recruitingStudy on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata
- Disease:Alopecia areata
- Substances:Baricitinib
Germany- Participants:0–17 years
- Substances:Baricitinib
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to Germany111 clinical trials in Bad Bentheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on plaque psoriasis and psoriatic arthritis are evaluating novel therapeutic approaches. Research includes comparative studies of new biological treatments and long-term safety assessments.
These studies aim to improve treatment outcomes for patients with varying severities of psoriatic conditions.
Innovative clinical trials are investigating treatments for atopic dermatitis and chronic hand eczema. Studies range from evaluating new biological therapies to investigating dose optimization strategies.
Research focuses on both adult and adolescent populations, with emphasis on long-term efficacy and safety.
Research initiatives addressing various dermatological conditions, including hidradenitis suppurativa, prurigo nodularis, and actinic keratosis. Novel therapeutic approaches are being tested.
These trials aim to develop targeted treatments for challenging skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.